Teva Defends IP Suit Over Generic MS Drug Research
Teva Pharmaceuticals Ltd. on Monday defended its patent suit over rival Sandoz Inc.'s attempt to develop a generic version of its multiple sclerosis drug Copaxone, saying legal safe harbors that protect...To view the full article, register now.
Already a subscriber? Click here to view full article